Level of Evidence for Labeled Dosing Recommendations in Renal Impairment

被引：0
|
作者：
Gagne, Joshua J.
Khan, Nazleen F.
Raj, Tara S.
Patel, Lajja R.
Choudhry, Niteesh K.
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
668
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [31] Evaluation of medication dosing errors in elderly patients with renal impairment
    Won, Hyo-Joong
    Chung, Gokyung
    Lee, Kyeong Ju
    Lee, Eunkyung
    Son, Soonjoo
    Choi, Soyoung
    Park, Seon Cheol
    Lee, Yu Jeung
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (08) : 358 - 365
  • [32] Recommended Methods of Drug Dosing Adjustment for Patients With Renal Impairment
    Erstad, Brian L.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (09) : 972 - 977
  • [33] Renal Impairment in Pediatric Patients: Current Approaches to Drug Dosing
    Khurana, Mona
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 : S161 - S164
  • [34] Evaluation of Hepatic Impairment Dosing Recommendations in FDA-Approved Product Labels
    Chang, Yang
    Burckart, Gilbert J.
    Lesko, Lawrence J.
    Dowling, Thomas C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (09): : 962 - 966
  • [35] Individualized Dosing of Enoxaparin for Subjects With Renal Impairment Is Superior to Conventional Dosing at Achieving Therapeutic Concentrations
    Barras, Michael A.
    Duffull, Stephen B.
    Atherton, John J.
    Green, Bruce
    THERAPEUTIC DRUG MONITORING, 2010, 32 (04) : 482 - 488
  • [36] The Impact of Multiple Renal Estimates on Pharmacist Dosing Recommendations: A Randomized Trial
    McConachie, Sean M.
    Hanni, Claudia M.
    Raub, Joshua N.
    Mohammad, Rima A.
    Wilhelm, Sheila M.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (01) : 25 - 35
  • [37] Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine
    Sweileh, Waleed M.
    Janem, Samah A.
    Sawalha, Ansam F.
    Abu-Taha, Adham S.
    Zyoud, Sa'ed H.
    Sabri, Iyad A.
    Al-Jabi, Samah W.
    Jaradat, Nidal A.
    Zaid, Abed Al-Naser M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (08) : 908 - 912
  • [38] Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
    Hitoshi Kawasuji
    Yasuhiro Tsuji
    Chika Ogami
    Kou Kimoto
    Akitoshi Ueno
    Yuki Miyajima
    Koyomi Kawago
    Ippei Sakamaki
    Yoshihiro Yamamoto
    BMC Pharmacology and Toxicology, 22
  • [39] Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
    Kawasuji, Hitoshi
    Tsuji, Yasuhiro
    Ogami, Chika
    Kimoto, Kou
    Ueno, Akitoshi
    Miyajima, Yuki
    Kawago, Koyomi
    Sakamaki, Ippei
    Yamamoto, Yoshihiro
    BMC PHARMACOLOGY & TOXICOLOGY, 2021, 22 (01):
  • [40] Dose recommendations for anticancer drugs in patients with renal or hepatic impairment
    Krens, Stefanie D.
    Lassche, Clerben
    Jansman, Frank G. A.
    Desar, Ingrid M. E.
    Lankheet, Nienke A. G.
    Burger, David M.
    van Herpen, Carla M. L.
    van Erp, Nielka P.
    LANCET ONCOLOGY, 2019, 20 (04): : E200 - E207
12345